-Develop and guide safety and health programs for 300 workforce members-Manage lab safety protocols and procedures for 20 laboratories, impacting 70 million dollars of biomedical research-Steered governance meetings (Institutional Safety, Biosafety, and Animal Care Committees) contributing to strategic decision-making and operational improvements-Developed and implemented new EHS policy and improved existing ones, resulting in an increase in safety protocol adherence-Provided expert technical support for EHS programs, directly leading to an increased culture of safety-awareness and 25% decrease in workplace injuries-Coached team members and operational leaders, fostering a culture of EHS ownership and best practices, including leading launch of departmental “Safety Leads”, an annual Safety Fair, and increased Safety Committee engagement-Institutional Safety, Animal Care and Use, and Biosafety Committee (IBC), membership in support of research protocols, and occupational health and safety.-Key Solutions eProtocol software development, maintenance, and user support -Cornerstone Learning Management System development and implementation for online and in-person EHS training modules.

IRB, IACUC, IBC management

-UW Biosafety and Animal Care and Use Committee member-Leading protocol review for animal research involving radioactive, biological chemical (RBC) substances requiring a comprehensive approach ensuring safety and compliance-Project risk assessment and management, ensuring protocols meet relevant regulations and guidelines-Collaborative project management with Information Technology for development of Access Biosafety Program database and further system management-Developed and presented Biosafety Training for research staff including Graduate Student Seminar surrounding research involving recombinant nucleic acids and biological hazards-Created auditing tool and documents for ensuring adherence to relevant NIH and CDC regulations Provided review, risk assessment for new biocontainment and animal use facilities

-Contract pharmaceutical and medical device research testing for market validation (adventitious virus, viral clearance, mycoplasma, and endotoxin)-Expert Biosafety Level (BSL)-1, BSL-2 and BSL-3 lab operation and maintenance-Bio-pharmaceutical group collaboration regarding Good Manufacturing Practices (GMP) adherence document development, use, and review-Emergency Response Team member

-Diagnostic test manufacturing-Cell culture, virus, and bacterial stock preparation-Research-exclusive protein production and purification-GMP-regulated document development, use, and review